BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35862462)

  • 1. Malignant peritoneal cytology in endometrial cancer: a contemporary review.
    Guo XM; Roman LD; Klar M; Wright JD; Matsuo K
    Expert Rev Anticancer Ther; 2022 Sep; 22(9):947-955. PubMed ID: 35862462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
    Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
    Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer.
    Tang X; Li N; Hu Y
    Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States.
    Matsuo K; Klar M; Harter P; Miller H; Nusbaum DJ; Matsuzaki S; Roman LD; Wright JD
    Gynecol Oncol; 2021 Jun; 161(3):710-719. PubMed ID: 33726962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M
    Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
    Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
    Wang L; Li L; Wu M; Lang J
    Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
    Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
    Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
    Seagle BL; Alexander AL; Lantsman T; Shahabi S
    Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis.
    Lee B; Suh DH; Kim K; No JH; Kim YB
    Jpn J Clin Oncol; 2016 Aug; 46(8):711-7. PubMed ID: 27207885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
    Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
    Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of positive peritoneal cytology in endometrial cancer patients.
    Behtash N; Sheikhhasani S; Nezamabadi V
    J Obstet Gynaecol; 2022 Aug; 42(6):2336-2340. PubMed ID: 35470766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature.
    Shiozaki T; Tabata T; Yamada T; Yamamoto Y; Yamawaki T; Ikeda T
    Int J Gynecol Cancer; 2014 Mar; 24(3):549-55. PubMed ID: 24476896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of surgical approach on prevalence of positive peritoneal cytology and lymph-vascular invasion in patients with early-stage endometrial carcinoma: a National Cancer Database study.
    Nasioudis D; Ko EM; Cory L; Latif N
    Int J Gynecol Cancer; 2021 Jul; 31(7):1001-1006. PubMed ID: 33853880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal cytology in endometrial cancer.
    Mlyncek M; Uharcek P
    Neoplasma; 2005; 52(2):103-8. PubMed ID: 15800707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer.
    Milgrom SA; Kollmeier MA; Abu-Rustum NR; Makker V; Gardner GJ; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Jul; 130(1):49-53. PubMed ID: 23603151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus.
    Kasamatsu T; Onda T; Katsumata N; Sawada M; Yamada T; Tsunematsu R; Ohmi K; Sasajima Y; Matsuno Y
    Br J Cancer; 2003 Jan; 88(2):245-50. PubMed ID: 12610496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleaved caspase-3 expression is a potential prognostic factor for endometrial cancer with positive peritoneal cytology.
    Ogane N; Yasuda M; Kato H; Kato T; Yano M; Kameda Y; Kamoshida S
    Cytopathology; 2018 Jun; 29(3):254-261. PubMed ID: 29626374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus.
    Obermair A; Geramou M; Tripcony L; Nicklin JL; Perrin L; Crandon AJ
    Cancer Lett; 2001 Mar; 164(1):105-10. PubMed ID: 11166922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.